Market Cap 91.10M
Revenue (ttm) 0.00
Net Income (ttm) -26.77M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 563,332
Avg Vol 1,021,486
Day's Range N/A - N/A
Shares Out 85.94M
Stochastic %K 33%
Beta 1.02
Analysts Strong Sell
Price Target $8.50

Company Profile

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutan...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 289 910 0850
Fax: 905 481 2394
Address:
2265 Upper Middle Road East, Suite 602, Oakville, Canada
mmtiddy
mmtiddy Oct. 9 at 6:33 PM
$CRDL Took them ages to submit this and to who? AHA? ACC? Who?
1 · Reply
jonboatjon
jonboatjon Oct. 9 at 5:21 PM
0 · Reply
HeyYio
HeyYio Oct. 9 at 2:59 PM
$CRDL "submitted for presentation at an upcoming scientific meeting and for publication" We in school? Prepping our thesis for a PhD? David let the large pharma look at the data with the NDAs. They know what to look for!! lets f'en goooooooo....
0 · Reply
BucketzUp
BucketzUp Oct. 9 at 1:35 PM
0 · Reply
Choppin_cotton
Choppin_cotton Oct. 9 at 1:26 PM
1 · Reply
BucketzUp
BucketzUp Oct. 9 at 11:31 AM
0 · Reply
BucketzUp
BucketzUp Oct. 9 at 4:59 AM
0 · Reply
Theo77
Theo77 Oct. 9 at 1:32 AM
$CRDL Here’s why CardiolRx is different: Targeting the root of inflammation-fibrosis via NLRP3 inhibition. Not just symptom control — upstream shutdown.
0 · Reply
HeyYio
HeyYio Oct. 8 at 11:44 PM
$CRDL I am making a declaration. Its almost time !! Volume is slowing down. Positions are established. Restricted shares were granted to execs on Oct 3. Bollinger bands squeezing (meaning volatility has been very low). Biotechnology index is at a 52week high. Pharma has trillions to spend. The Donald likes cannabis based medicine. Nasdaq is roaring. It's now or never. Open the data room David and make a deal with a top 5 pharma !!
0 · Reply
Iceberg99
Iceberg99 Oct. 8 at 10:27 PM
0 · Reply
Latest News on CRDL
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index

Nov 13, 2024, 8:00 AM EST - 11 months ago

Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index


mmtiddy
mmtiddy Oct. 9 at 6:33 PM
$CRDL Took them ages to submit this and to who? AHA? ACC? Who?
1 · Reply
jonboatjon
jonboatjon Oct. 9 at 5:21 PM
0 · Reply
HeyYio
HeyYio Oct. 9 at 2:59 PM
$CRDL "submitted for presentation at an upcoming scientific meeting and for publication" We in school? Prepping our thesis for a PhD? David let the large pharma look at the data with the NDAs. They know what to look for!! lets f'en goooooooo....
0 · Reply
BucketzUp
BucketzUp Oct. 9 at 1:35 PM
0 · Reply
Choppin_cotton
Choppin_cotton Oct. 9 at 1:26 PM
1 · Reply
BucketzUp
BucketzUp Oct. 9 at 11:31 AM
0 · Reply
BucketzUp
BucketzUp Oct. 9 at 4:59 AM
0 · Reply
Theo77
Theo77 Oct. 9 at 1:32 AM
$CRDL Here’s why CardiolRx is different: Targeting the root of inflammation-fibrosis via NLRP3 inhibition. Not just symptom control — upstream shutdown.
0 · Reply
HeyYio
HeyYio Oct. 8 at 11:44 PM
$CRDL I am making a declaration. Its almost time !! Volume is slowing down. Positions are established. Restricted shares were granted to execs on Oct 3. Bollinger bands squeezing (meaning volatility has been very low). Biotechnology index is at a 52week high. Pharma has trillions to spend. The Donald likes cannabis based medicine. Nasdaq is roaring. It's now or never. Open the data room David and make a deal with a top 5 pharma !!
0 · Reply
Iceberg99
Iceberg99 Oct. 8 at 10:27 PM
0 · Reply
PDM21
PDM21 Oct. 8 at 9:59 PM
$CRDL so there is absolutely an embargo clause for the data submitted for the AHA meeting, certainly the AHA will disclose that they werent accepted if that’s the case. Got to be any time now if they haven’t already, late applications were due August 4
1 · Reply
NancyPelosi____insider
NancyPelosi____insider Oct. 8 at 8:48 PM
0 · Reply
BucketzUp
BucketzUp Oct. 8 at 7:05 PM
0 · Reply
BucketzUp
BucketzUp Oct. 8 at 6:35 PM
0 · Reply
BucketzUp
BucketzUp Oct. 8 at 5:17 PM
0 · Reply
BucketzUp
BucketzUp Oct. 8 at 5:13 PM
0 · Reply
BucketzUp
BucketzUp Oct. 8 at 4:25 PM
$VMAR Zacks short-term price target of $10.00 for Vision Marine Technologies Inc. Rocket 🚀 time https://www.zacks.com/stock/research/VMAR/price-target-stock-forecast $BULL $CRSP $CRDL $GLD
0 · Reply
Covode13
Covode13 Oct. 8 at 3:14 PM
0 · Reply
HeyYio
HeyYio Oct. 8 at 1:17 PM
$CRDL will you let us know when to get back in ?
1 · Reply
mmtiddy
mmtiddy Oct. 8 at 1:14 PM
$CRDL With no upcoming catalysts this thing will bleed badly, reminder to stay away from this stock
0 · Reply
HeyYio
HeyYio Oct. 8 at 12:46 PM
$CRDL due to 7 weeks of a tight trading range and significant volume the Bollinger Bands are tighter than.... (fill in the rest folks) .
0 · Reply
andywaffen
andywaffen Oct. 8 at 8:09 AM
$CRDL wow. Any news?
1 · Reply